Clinical Trial Update: POLA-R-CHP in the First-line Treatment of Transformed DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating polatuzumab vedotin in combination with R-CHP for first-line treatment of transformed diffuse large B-cell lymphoma is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transformed Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Polivy (polatuzumab vedotin)
• Rituxan (rituximab)

Snippet

Sponsor: Fudan University | Conditions: Transformed Lymphoma | Phase 2 | Status: RECRUITING